Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stoll

Showing results (341-350 of 377) with videos related to

Pageof 38
Sort By:
The Prostate|January 31, 2007
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells--a pilot studyB Hildenbrand, B Sauer, O Kalis, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|October 2, 2014
Policy and system change and community coalitions: outcomes from allies against asthmaNoreen M Clark, Laurie Lachance, Linda Jo Doctor, et al.
Annals of the Rheumatic Diseases|March 11, 2016
PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritisP Luz-Crawford, N Ipseiz, G Espinosa-Carrasco, et al.
American Journal of Public Health|March 20, 2010
Policy and system change and community coalitions: outcomes from allies against asthmaNoreen M Clark, Laurie Lachance, Linda Jo Doctor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2012
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306S Stintzing, L Fischer von Weikersthal, T Decker, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2023
Introducing a standardized assessment of patients' interest in and usage of CAM in routine cancer care: chances and risks from patients' and physicians' point of viewM Shalgouny, J Bertz-Lepel, L Fischer V Weikersthal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2021
Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBSKathryn M Miller, Joseph R Patterson, Joseph Kochmanski, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2024
AAV9-Mediated Intrastriatal Delivery of <i>GNAO1</i> Reduces Hyperlocomotion in <i>Gnao1</i> Heterozygous R209H Mutant MiceAlex J Roy, Jeffrey R Leipprandt, Joseph R Patterson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 1, 1997
[Fragile X syndrome is still unrecognized: efficacy of molecular diagnosis in mentally retarded probands]M Cossée, C Moutou, V Biancalana, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 22, 2023
Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected miceSierra L Boyd, Nathan C Kuhn, Joseph R Patterson, et al.
Pageof 38

Showing results (341-350 of 377) with videos related to

Sort By:
Pageof 38
The Prostate|January 31, 2007
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells--a pilot studyB Hildenbrand, B Sauer, O Kalis, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|October 2, 2014
Policy and system change and community coalitions: outcomes from allies against asthmaNoreen M Clark, Laurie Lachance, Linda Jo Doctor, et al.
Annals of the Rheumatic Diseases|March 11, 2016
PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritisP Luz-Crawford, N Ipseiz, G Espinosa-Carrasco, et al.
American Journal of Public Health|March 20, 2010
Policy and system change and community coalitions: outcomes from allies against asthmaNoreen M Clark, Laurie Lachance, Linda Jo Doctor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2012
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306S Stintzing, L Fischer von Weikersthal, T Decker, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2023
Introducing a standardized assessment of patients' interest in and usage of CAM in routine cancer care: chances and risks from patients' and physicians' point of viewM Shalgouny, J Bertz-Lepel, L Fischer V Weikersthal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2021
Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBSKathryn M Miller, Joseph R Patterson, Joseph Kochmanski, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2024
AAV9-Mediated Intrastriatal Delivery of <i>GNAO1</i> Reduces Hyperlocomotion in <i>Gnao1</i> Heterozygous R209H Mutant MiceAlex J Roy, Jeffrey R Leipprandt, Joseph R Patterson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 1, 1997
[Fragile X syndrome is still unrecognized: efficacy of molecular diagnosis in mentally retarded probands]M Cossée, C Moutou, V Biancalana, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 22, 2023
Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected miceSierra L Boyd, Nathan C Kuhn, Joseph R Patterson, et al.
Pageof 38